Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | MMP2 | P08253 | 1/20 | 0.54 |
| ▸ | MMP9 | P14780 | 1/20 | 0.54 |
| ▸ | MMP8 | P22894 | 1/20 | 0.54 |
| ▸ | MMP14 | P50281 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 5/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.51 |
| ▸ | MAPT | P10636 | 4/20 | 0.51 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL409050 | 1.00 | CA12 (0.54) | CA12CA14CA2MMP2MMP9 | |
| SCHEMBL298855 | 1.00 | CA12 (0.54) | CA12CA14CA2MMP2MMP9 | |
| SCHEMBL29367675 | 1.00 | CA12 (0.54) | CA12CA14CA2MMP2MMP9 | |
| SCHEMBL29478385 | 1.00 | CA12 (0.54) | CA12CA14CA2MMP2MMP9 | |
| SCHEMBL42286 | 1.00 | CA12 (0.54) | CA12CA14CA2MMP2MMP9 | |
| Hydrochloric Acid SCHEMBL21433626 | 0.98 | CA12 (0.53) | CA12CA14CA2MMP2MMP9 | |
| Ammonia Solution, Strong SCHEMBL466944 | 0.98 | CA12 (0.53) | CA12CA14CA2MMP2MMP9 | |
| Hydrochloric Acid SCHEMBL21433625 | 0.98 | CA12 (0.53) | CA12CA14CA2MMP2MMP9 | |
| Ammonia Solution, Strong SCHEMBL466943 | 0.98 | CA12 (0.53) | CA12CA14CA2MMP2MMP9 | |
| Hydrochloric Acid SCHEMBL6420699 | 0.98 | CA12 (0.53) | CA12CA14CA2MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 21297 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070295-A | Insect neuropeptide analogs | 索拉斯塔生物有限公司 | 2026-05-19 | — | — | CN | claimed |
| US-12630588-B2 | Bicyclic peptide ligands specific for CD137 | BICYCLETX LIMITED (GB) | 2026-05-19 | — | — | US | claimed |
| CN-122070296-A | Insect neuropeptide analogs | 索拉斯塔生物有限公司 | 2026-05-19 | — | — | CN | claimed |
| WO-2026088112-A1 | COMBINATION THERAPIES WITH AR-DEGRADING AGENTS AND PSMA-TARGETING RADIOLIGANDS | NOVARTIS AG (CH) | 2026-04-30 | — | — | WO | claimed |
| EP-4719353-A1 | REVERSIBLE SURFACTANT AND MULTIFUNCTIONAL DRUG DELIVERY SYSTEMS BASED THEREON | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2026-04-08 | — | — | EP | claimed |
| EP-4719486-A1 | CONJUGATES AND USES THEREOF | Full-Life Technologies UK Limited (GB) | 2026-04-08 | — | — | EP | claimed |
| EP-4717776-A2 | POLYPEPTIDE CONJUGATES FOR INTRACELLULAR DELIVERY OF NUCLEIC ACIDS | Ohio State Innovation Foundation (US) | 2026-04-01 | — | — | EP | claimed |
| EP-4709739-A1 | ANTI-BACTERIAL PEPTIDES | Agency for Science, Technology and Research (SG) | 2026-03-18 | — | — | EP | claimed |
| US-20260070947-A1 | CYCLIC CELL-PENETRATING PEPTIDE COMPOUNDS | OHIO STATE INNOVATION FOUNDATION (US) | 2026-03-12 | — | — | US | claimed |
| US-12552837-B2 | Bicyclic peptide ligands with detectable moieties and uses thereof | Bicyclerd Limited (GB) | 2026-02-17 | — | — | US | claimed |
| EP-0230242-A2 | Substituted derivatives of 4-amino-3-hydroxy-butyric acid, process for their production, medicines containing them, and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-07-29 | — | — | EP | claimed |
| US-4673665-A | INDUCE OVULATION BY USING A GESTAGEN FOLLOWED BY LUTEINIZING HORMONE | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-06-16 | — | — | US | claimed |
| EP-0215171-A2 | Peptides | THE ADMINISTRATORS OF THE TULANE UNIVERSITY EDUCATIONAL FUND (US) | 1987-03-25 | — | — | EP | claimed |
| EP-0192742-A1 | CYCLIC POLYPEPTIDES HAVING MU-RECEPTOR SPECIFICITY | GIBSON-STEPHENS NEUROPHARMACEUTICALS, INC. (US) | 1986-09-03 | — | — | EP | claimed |
| EP-0184550-A2 | 5-Amino-4-hydroxy valeryl amide derivatives | CIBA-GEIGY AG (CH) | 1986-06-11 | — | — | EP | claimed |
| WO-1986001516-A1 | CYCLIC POLYPEPTIDES HAVING MU-RECEPTOR SPECIFICITY | GIBSON-STEPHENS NEUROPHARMACEUTICALS, INC. (US) | 1986-03-13 | — | — | WO | claimed |
| EP-0171477-A2 | Amino acid-containing therapeutic compounds | THE ADMINISTRATORS OF THE TULANE UNIVERSITY EDUCATIONAL FUND (US) | 1986-02-19 | — | — | EP | claimed |
| EP-0162414-A2 | Amphipathic peptides and pharmaceutical compositions containing same | Research Corporation (US) | 1985-11-27 | — | — | EP | claimed |
| EP-0156280-A2 | Process for the preparation of peptide intermediates poor in racemates, belonging to gonadorelin and gonadorelin analogues, their synthesis and intermediates obtained by this process | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-10-02 | — | — | EP | claimed |
| EP-0155809-A2 | Renin inhibitors containing statine or derivatives thereof | PFIZER INC. (US) | 1985-09-25 | — | — | EP | claimed |